Metabolism of Octanoate and Its Effect on Glucose and Palmitate Utilization by Isolated Fat Cells von Maragoudakis, Michael E., Kalinsky, Helen J., Lennane, Joyce

Volltext

CGS 8216: Receptor binding characteristics of a potent benzodiazepine antagonist von Czernik, Andrew J., Petrack, Barbara, Kalinsky, Helen J., Psychoyos, Stacy, Cash, William D., Tsai, Cindy, Rinehart, Roy K., Granat, Frank R., Lovell, Richard A., Brundish, Derek E., Wade, Roy

Volltext

Changes in serum inorganic phosphorus during intravenous glucose tolerance tests: in patients with primary (essential) hypertension, other disease states, and in normal man von WERTHEIM, A R, EURMAN, G H, KALINSKY, H J

Volltext

The origin of urinary creatine in progressive muscular dystrophy von BENEDICT, J D, KALINSKY, H J, SCARRONE, L A, WERTBEIM, A R, STETTEN, Jr, D

Volltext

Determination of deoxycholic and cholic acids in bile von Mosbach, Erwin H., Kalinsky, Helen J., Halpern, Evelyn, Kendall, Forrest E.

Volltext

Tryptophan pyrolase activity during pregnancy von Greengard, P., Kalinsky, H.J., Manning, T.J.

Volltext

Biomarker analyses in the phase III ASCENT study of sacituzumab govitecan versus chemotherapy in patients with metastatic triple-negative breast cancer von Bardia, A., Tolaney, S.M., Punie, K., Loirat, D., Oliveira, M., Kalinsky, K., Zelnak, A., Aftimos, P., Dalenc, F., Sardesai, S., Hamilton, E., Sharma, P., Recalde, S., Gil, E.C., Traina, T., O’Shaughnessy, J., Cortes, J., Tsai, M., Vahdat, L., Diéras, V., Carey, L.A., Rugo, H.S., Goldenberg, D.M., Hong, Q., Olivo, M., Itri, L.M., Hurvitz, S.A.

Volltext

Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer von Bardia, Aditya, Mayer, Ingrid A, Vahdat, Linda T, Tolaney, Sara M, Isakoff, Steven J, Diamond, Jennifer R, O’Shaughnessy, Joyce, Moroose, Rebecca L, Santin, Alessandro D, Abramson, Vandana G, Shah, Nikita C, Rugo, Hope S, Goldenberg, David M, Sweidan, Ala M, Iannone, Robert, Washkowitz, Sarah, Sharkey, Robert M, Wegener, William A, Kalinsky, Kevin

Volltext

Identification of hormonally controlled endogenous inhibitor of liver nicotinamide deamidase von Greengard, Paul, Petrack, Barbara, Kalinsky, Helen J.

Volltext

Release of inhibition of rat liver nicotinamide deamidase by hypophysectomy von Greengard, Paul, Petrack, Barbara, Craston, Ann, Kalinsky, Helen J.

Volltext

Risk-adapted modulation through de-intensification of cancer treatments: an ESMO classification von Trapani, D., Franzoi, M.A., Burstein, H.J., Carey, L.A., Delaloge, S., Harbeck, N., Hayes, D.F., Kalinsky, K., Pusztai, L., Regan, M.M., Sestak, I., Spanic, T., Sparano, J., Jezdic, S., Cherny, N., Curigliano, G., Andre, F.

Volltext

21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer von Kalinsky, Kevin, Barlow, William E, Gralow, Julie R, Meric-Bernstam, Funda, Albain, Kathy S, Hayes, Daniel F, Lin, Nancy U, Perez, Edith A, Goldstein, Lori J, Chia, Stephen K.L, Dhesy-Thind, Sukhbinder, Rastogi, Priya, Alba, Emilio, Delaloge, Suzette, Martin, Miguel, Kelly, Catherine M, Ruiz-Borrego, Manuel, Gil-Gil, Miguel, Arce-Salinas, Claudia H, Brain, Etienne G.C, Lee, Eun-Sook, Pierga, Jean-Yves, Bermejo, Begoña, Ramos-Vazquez, Manuel, Jung, Kyung-Hae, Ferrero, Jean-Marc, Schott, Anne F, Shak, Steven, Sharma, Priyanka, Lew, Danika L, Miao, Jieling, Tripathy, Debasish, Pusztai, Lajos, Hortobagyi, Gabriel N

Volltext

Pre-surgical trial of the AKT inhibitor MK-2206 in patients with operable invasive breast cancer: a New York Cancer Consortium trial von Kalinsky, K., Sparano, J. A., Zhong, X., Andreopoulou, E., Taback, B., Wiechmann, L., Feldman, S. M., Ananthakrishnan, P., Ahmad, A., Cremers, S., Sireci, A. N., Cross, J. R., Marks, D. K., Mundi, P., Connolly, E., Crew, K. D., Maurer, M. A., Hibshoosh, H., Lee, S., Hershman, D. L.

Volltext

273TiP ACE-Breast-03: A phase II study patients with HER2-positive metastatic breast cancer whose disease is resistant or refractory to T-DM1, and/or T-DXd, and/or tucatinib-contai... von Hurvitz, S.A., Kalinsky, K., Tripathy, D., Sledge, G., Gradishar, W.J., O'Shaughnessy, J., Modi, S., Park, H., McCartney, A., Frentzas, S., Shannon, C., Cuff, K., Eek, R.W., Martin Jimenez, M., Curigliano, G., Jerusalem, G., Huang, C., Press, M., Lu, J.

Volltext

38-OR: Implementation of an EHR-Integrated Hospital-Wide CGM Protocol for Insulin Dosing von Seav, Susan M, Lee, Ming Yeh, Ongwela, Loice, Aubyrn, Rachel, Cao, Fang, Lee, Julie JH, Kalinsky, Anna F, Ramos, Olivia M Aparicio, Gu, Yunzi M, Ivanovic, Maja M, Buckingham, Bruce A, Desai, Dimpi, Lal, Rayhan, Tan, Marilyn, Basina, Marina, Hughes, Michael S

Volltext

Abstract SP012: Convergent evolution of resistance pathways during early stage breast cancer treatment with combination cell cycle (CDK) and endocrine signaling inhibitors von Griffiths, JI, Chen, J, Cosgrove, PA, O'Dea, A, Sharma, P, Ma, CX, Trivedi, M, Kalinsky, K, Wisinski, KB, O'Reagan, R, Makhoul, I, Spring, LM, Bardia, A, Adler, FR, Cohen, AL, Chang, JT, Khan, QJ, Bild, AH

Volltext

Abstract P6-20-07: Efficacy and safety of CB-839, a small molecule inhibitor of glutaminase, in combination with paclitaxel in patients with advanced triple negative breast cancer... von Vidal, G, Kalinsky, K, Stringer-Reasor, E, Lynce, F, Cole, J, Valdes-Albini, F, Soliman, H, Nikolinakos, P, Silber, A, DeMichele, A, Ali, H, Graham, D, Giguere, J, Brufsky, A, Liang, Y, Holland, S, Fiji, G, O'Keeffe, B, Gogineni, K

Volltext

Abstract OT1-03-08: A multicenter, phase I/II trial of anastrozole, palbociclib, trastuzumab and pertuzumab in HR-positive, Her2-positive metastatic breast cancer von Cascetta, KP, Poulikakos, P, Shapiro, C, Fasano, J, Bhardwaj, A, Irie, H, Goel, A, Klein, P, Adams, S, Kalinsky, K, Vahdat, L, Ru, M, Tiersten, A

Volltext

Serial single-cell genomics reveals convergent subclonal evolution of resistance as patients with early-stage breast cancer progress on endocrine plus CDK4/6 therapy von Griffiths, Jason I., Chen, Jinfeng, Cosgrove, Patrick A., O’Dea, Anne, Sharma, Priyanka, Ma, Cynthia, Trivedi, Meghna, Kalinsky, Kevin, Wisinski, Kari B., O’Regan, Ruth, Makhoul, Issam, Spring, Laura M., Bardia, Aditya, Adler, Frederick R., Cohen, Adam L., Chang, Jeffrey T., Khan, Qamar J., Bild, Andrea H.

Volltext

Abstract P2-03-01: Akt inhibition associated with change in immunophenotype of tumor microenvironment (TME) in breast cancer (BC) von Marks, DK, Gartrell, RD, Pan, Q, El Asmar, M, Hart, TD, Esancy, CL, Lu, Y, Yu, J, Hibshoosh, H, Connolly, E, Kalinsky, K, Saenger, YM

Volltext